Breast Cancer

Widespread reductions in cancer screenings during the COVID-19 pandemic may be associated with delayed cancer diagnoses and increased mortality for breast, cervical and colon cancers, according to study results published in JAMA Oncology.

Healio rounded up the top breast cancer coverage presented and discussed at ASCO Annual Meeting in Chicago.

More than one in seven breast cancer survivors reported persistent financial hardship within 5 years of diagnosis, according to study results.

In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more.

Despite strides in cancer care and treatment, disparities in breast cancer outcomes still remain for women of color when compared with white women.

According to a new report from the American Cancer Society, in collaboration with the National Cancer Institute, the number of cancer survivors in the United States has risen to 18 million.

Increases in BMI and abdominal obesity appeared associated with higher risk for male breast cancer, according to study results published in Cancer Epidemiology.

Availability of oral anticancer medications has increased greatly during the past decade, offering patients the convenience of fewer appointments, less travel time and targeted treatment within the comfort of their homes.

Active systemic cancer treatment did not appear associated with increased mortality among patients with cancer and COVID-19, according to study results published in JAMA Network Open.

Nitika Sharma, MD, said that she was driven to oncology based on a mission of providing compassionate care to patients undergoing treatment for cancer.